[Therapeutic options in juvenile idiopathic arthritis : Part 1: Nonsurgical treatment]
- PMID: 30291372
- DOI: 10.1007/s00132-018-3645-1
[Therapeutic options in juvenile idiopathic arthritis : Part 1: Nonsurgical treatment]
Abstract
The treatment of children and adolescents with juvenile idiopathic arthritis (JIA) has progressed substantially during recent years. Multiple different factors have played a role in this advancement: improved medical treatment due to the introduction of new drugs, structural improvements with provision of units specializing in childhood rheumatology, multidisciplinary treatment concepts, structured educational programs for patients and parents, improved functional treatment including sports therapy, and selective surgical and orthopedic interventions improving functional capacities. Current treatment strategies in JIA are aimed at achieving disease remission, i.e., control of disease activity and re-establishment of age-appropriate functional capacities. This review summarizes important developments in the conservative treatment of JIA. Part 2 deals with orthopedic and surgical treatment strategies.
Keywords: Adolescent health; Antirheumatic agents; Biologics; Transition to adult care; Uveitis, anterior.
Similar articles
-
[Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].Reumatizam. 2013;60(1):57-66. Reumatizam. 2013. PMID: 24003687 Croatian.
-
Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.Arthritis Rheumatol. 2014 Sep;66(9):2580-9. doi: 10.1002/art.38741. Arthritis Rheumatol. 2014. PMID: 24942886
-
Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.Rheumatology (Oxford). 2013 Nov;52(11):1999-2003. doi: 10.1093/rheumatology/ket256. Epub 2013 Jul 27. Rheumatology (Oxford). 2013. PMID: 23893666
-
Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.Arthritis Res Ther. 2009;11(1):216. doi: 10.1186/ar2619. Epub 2009 Feb 23. Arthritis Res Ther. 2009. PMID: 19291269 Free PMC article. Review.
-
Novel treatment options for juvenile idiopathic arthritis.Expert Rev Clin Pharmacol. 2015;8(5):559-73. doi: 10.1586/17512433.2015.1061428. Expert Rev Clin Pharmacol. 2015. PMID: 26294075 Review.
Cited by
-
[Rheumatic pain and chronic pain in children, adolescents and young adults].Z Rheumatol. 2021 Apr;80(3):234-242. doi: 10.1007/s00393-020-00956-3. Epub 2021 Jan 8. Z Rheumatol. 2021. PMID: 33416985 Review. German.
-
[Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis].Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1014-1022. doi: 10.19723/j.issn.1671-167X.2020.06.005. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33331307 Free PMC article. Chinese.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical